Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | ADP-A2M4 cells |
Trade Name | |
Synonyms | MAGE-A4 SPEAR T cells|autologous TCR-transduced MAGE-A4 C1032 T cells |
Drug Descriptions |
ADP-A2M4 cells are autologous T-cells that are modified to express a T-cell receptor that recognizes the human melanoma antigen 4 (MAGE-A4) peptide region from 230-239, which potentially inhibits growth of MAGE-A4-expressing tumor cells (PMID: 32002290). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C138107 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ADP-A2M4 cells | ADP-A2M4 cells | 0 | 3 |
ADP-A2M4 cells + Nivolumab | ADP-A2M4 cells Nivolumab | 0 | 1 |
ADP-A2M4 cells + Pembrolizumab | ADP-A2M4 cells Pembrolizumab | 0 | 1 |